Joel Dudley Will Lead Biotech Investments At Google CEO’s Ex-Venture Capital Firm


Innovation Endeavors, the venture capital firm co-founded by former Google Chairman and CEO Eric Schmidt, is tapping one of the few researchers who’s seen through Theranos to help grow its investments in biotechnology.

The company has hired Joel Dudley as a biotech associate. Until recently, Dudley served as chief scientific officer at Tempus, a health-tech unicorn that is developing a system that can answer doctors’ questions about cancer on the spot. Before Tempus, Dudley was a researcher at the Icahn School of Medicine at Mount Sinai, where he and a team conducted one of the few published studies of Theranos blood tests, finding problems with his cholesterol readings.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


TO START UP = function( eventName, parameters ) { jQuery.ajax( { url: ‘/wp-json/stat-analytics/v1/facebook-pixel’, type: ‘POST’, data: { event_name: !eventName?null: eventName, parameters:!parameters?{}:parameters, source_url: window.location.href }, success: function( data, textStatus, jqXHR ) { //console.log( data ); }, error: function ( jqXHR, textStatus, errorThrown ) { //console.log( jqXHR ); } } ); };

jQuery( window ).on( ‘load’, function() { if (!window.bgmpGdpr || window.bgmpGdpr.isOptedOut() ) { return; }

!function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function(){n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!f._fbq)f._fbq=n; n.push=n;n.loaded=!0;n.version=’2.0′;n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window, document,’script’,’’);

fbq(‘init’, ‘436331036555416’); fbq(‘track’, ‘PageView’);

if ( ‘object’ === typeof mc4wp && mc4wp.forms ) { mc4wp.forms.on( ‘subscribed’, function() { // Successful MC4WP newsletter signup AJAX form submission. ‘Lead ‘ ); } ); }‘ViewContent’); } );

Leave a Comment